Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Chronotherapeutics: the relevance of timing in cancer therapy.

Lévi F.

Cancer Causes Control. 2006 May;17(4):611-21. Review.

PMID:
16596317
2.

Cancer chronotherapy: principles, applications, and perspectives.

Mormont MC, Levi F.

Cancer. 2003 Jan 1;97(1):155-69. Review.

3.
4.

Circadian chronotherapy for human cancers.

Lévi F.

Lancet Oncol. 2001 May;2(5):307-15. Review.

PMID:
11905786
5.

From circadian rhythms to cancer chronotherapeutics.

Lévi F.

Chronobiol Int. 2002 Jan;19(1):1-19. Review.

PMID:
11962669
6.

Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.

Lévi F, Focan C, Karaboué A, de la Valette V, Focan-Henrard D, Baron B, Kreutz F, Giacchetti S.

Adv Drug Deliv Rev. 2007 Aug 31;59(9-10):1015-35. Epub 2007 Jul 4. Review.

PMID:
17692427
7.

[Chronopharmacology and chronotherapy of cancers].

Lévi F.

Pathol Biol (Paris). 1996 Sep;44(7):631-44. Review. French.

PMID:
8977920
8.

Therapeutic implications of circadian rhythms in cancer patients.

Lévi F.

Novartis Found Symp. 2000;227:119-36; discussion 136-42. Review.

PMID:
10752068
9.

Tumor-based rhythms of anticancer efficacy in experimental models.

Granda TG, Lévi F.

Chronobiol Int. 2002 Jan;19(1):21-41. Review.

PMID:
11962677
10.

Circadian timing in cancer treatments.

Lévi F, Okyar A, Dulong S, Innominato PF, Clairambault J.

Annu Rev Pharmacol Toxicol. 2010;50:377-421. doi: 10.1146/annurev.pharmtox.48.113006.094626. Review.

PMID:
20055686
11.

[The circadian-timing system: a determinant of drug activity and a target of anticancer treatments].

Lévi F.

Ann Pharm Fr. 2008 Jun;66(3):175-84. doi: 10.1016/j.pharma.2008.05.003. Review. French.

PMID:
18706346
12.

Chronotherapy of colorectal cancer metastases.

Lévi F, Giacchetti S, Zidani R, Brezault-Bonnet C, Tigaud JM, Goldwasser F, Misset JL.

Hepatogastroenterology. 2001 Mar-Apr;48(38):320-2. Review.

PMID:
11379299
13.

Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics.

Lévi F, Filipski E, Iurisci I, Li XM, Innominato P.

Cold Spring Harb Symp Quant Biol. 2007;72:465-75. doi: 10.1101/sqb.2007.72.030. Review.

PMID:
18419306
14.

Chronotherapy of cancer: biological basis and clinical application.

Lévi F.

Pathol Biol (Paris). 1994 Apr;42(4):338-41. Review.

PMID:
7808787
15.

Chronotherapy for gastrointestinal cancers.

Lévi F.

Curr Opin Oncol. 1996 Jul;8(4):334-41. Review.

PMID:
8869810
16.

Chronotherapy and the molecular clock: Clinical implications in oncology.

Innominato PF, Lévi FA, Bjarnason GA.

Adv Drug Deliv Rev. 2010 Jul 31;62(9-10):979-1001. doi: 10.1016/j.addr.2010.06.002. Epub 2010 Jun 23. Review.

PMID:
20600409
17.

The circadian timing system in clinical oncology.

Innominato PF, Roche VP, Palesh OG, Ulusakarya A, Spiegel D, Lévi FA.

Ann Med. 2014 Jun;46(4):191-207. doi: 10.3109/07853890.2014.916990. Review.

PMID:
24915535
18.

Cancer chronotherapy.

Lévi F.

J Pharm Pharmacol. 1999 Aug;51(8):891-8. Review.

PMID:
10504026
19.

Circadian chemotherapy for gynecological and genitourinary cancers.

Kobayashi M, Wood PA, Hrushesky WJ.

Chronobiol Int. 2002 Jan;19(1):237-51. Review.

PMID:
11962679
20.

Biological perspectives on circadian cancer therapy.

Wood PA, Hrushesky WJ.

J Infus Chemother. 1995 Fall;5(4):182-90. Review.

PMID:
8934723
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk